Adrian Senderowicz Joins Constellation Pharma as Chief Medical Officer

Xconomy Boston — 

Constellation Pharmaceuticals has appointed Adrian Senderowicz senior vice president and chief medical officer. Before joining Constellation, a Cambridge, MA-based cancer immunotherapy developer, Senderowicz was chief medical officer at Waltham, MA-based Cerulean Pharma (NASDAQ: CERU). His experience includes positions at Ignyta (NASDAQ: RXDX), Sanofi Oncology (NYSE: SNY), Tokai Pharmaceuticals, and AstraZeneca (NYSE: AZN). Senderowicz also worked in the FDA’s Center for Drug Evaluation Research in the division that reviews oncology products.